Gene J. Yao is of counsel in Barnes & Thornburg's Delaware office, where he is a member of the firm's Intellectual Property Department. Gene focuses his multifaceted intellectual property practice on the biotech, chemical and pharmaceutical arts.
His practice includes virtually all aspects of IP law, including domestic and international patent preparation and prosecution, patent enforcement, counseling, opinion rendering, due diligence, post-grant patent practice, IP licensing, and patent portfolio management and litigation. He uses his scientific background in biochemistry, chemistry and molecular biology to provide valuable insights to his clients.
Gene has counseled biotech, chemical and pharmaceutical clients on a variety of life sciences issues, including patent application, portfolio management and license and agreement work. He has experience in a number of specific technological areas, including small and large molecules, pharmaceuticals, genomics, proteomics, therapeutic antibodies, therapeutic biologics, gene therapies, recombinant DNA, antimicrobial therapies, immunoassays, formulations, pharmaceutical compounding, transgenic animals, diagnostics, personalized health care, medical devices, fertilizers, polymers and cleaning materials and cosmetics.
Additionally, he has represented clients on drug product exclusivities, investigational new drug applications, new drug applications and abbreviated new drug applications, safe harbor, biosimilars, life-cycle management, target clearance, Hatch-Waxman issues and Orange Book patent matters.
Gene is a former senior counsel at Roche Pharmaceuticals, where he was the primary U.S. patent attorney in the metabolic and cardiovascular diseases and disorders therapeutic areas. He also counseled oncology and central nervous system areas.